People / Staff

F. Xavier Palomer Tarridas

Search publications

Publications

  • Barroso E, Eyre E, Palomer FX and Vazquez M.

    The peroxisome proliferator-activated receptor ß/d (PPARß/d) agonist GW501516 prevents TNF-a-induced NF-?B activation in human HaCaT cells by reducing p65 acetylation through AMPK and SIRT1.

    BIOCHEMICAL PHARMACOLOGY . 81(4): 534-543. Number of citations: 62

    [doi:10.1016/j.bcp.2010.12.004]

  • Alvarez-Guardia D, Palomer FX, Coll T, Serrano L, Rodríguez-Calvo R, Davidson MM, Merlos M, El Kochairi I, Michalik L, Wahli W and Vazquez M.

    PPARß/d activation blocks lipid-induced inflammatory pathways in mouse heart and human cardiac cells.

    BIOCHIMICA ET BIOPHYSICA ACTA-PROTEINS AND PROTEOMICS . 1811(2): 59-67. Number of citations: 65

    [doi:10.1016/j.bbalip.2010.11.002]

  • Alvarez-Guardia D, Palomer FX, Coll T, Davidson MM, Chan TO, Feldman AM, Laguna JC and Vazquez M.

    The p65 subunit of NF-kappaB binds to PGC-1alpha, linking inflammation and metabolic disturbances in cardiac cells.

    CARDIOVASC RES . 87(3): 449-458. Number of citations: 156

    [doi:10.1093/cvr/cvq080]

  • Coll T, Barroso E, Alvarez-Guardia D, Serrano L, Salvadó L, Merlos M, Palomer FX and Vazquez M.

    The Role of Peroxisome Proliferator-Activated Receptor beta/delta on the Inflammatory Basis of Metabolic Disease.

    PPAR Research . 2010: . Number of citations: 22

    [doi:10.1155/2010/368467]

  • Coll T, Alvarez-Guardia D, Barroso E, Gómez-Foix AM, Palomer FX, Laguna JC and Vazquez M.

    Activation of peroxisome proliferator-activated receptor-{delta} by GW501516 prevents fatty acid-induced nuclear factor-{kappa}B activation and insulin resistance in skeletal muscle cells.

    Endocrinology . 151(4): 1560-1569. Number of citations: 74

    [doi:10.1210/en.2009-1211]

  • Coll T, Palomer FX, Blanco-Vaca F, Escolà-Gil JC, Sánchez RM, Laguna JC and Vazquez M.

    Cyclooxygenase 2 inhibition exacerbates palmitate-induced inflammation and insulin resistance in skeletal muscle cells.

    Endocrinology . 151(2): 537-548. Number of citations: 54

    [doi:10.1210/en.2009-0874]

  • Palomer FX, Alvarez-Guardia D, Rodríguez-Calvo R, Coll T, Laguna JC, Davidson MM, Chan TO, Feldman AM and Vazquez M.

    TNF-alpha reduces PGC-1alpha expression through NF-kappaB and p38 MAPK leading to increased glucose oxidation in a human cardiac cell model.

    CARDIOVASC RES . 81(4): 703-712. Number of citations: 144

    [doi:10.1093/cvr/cvn327]

  • Rodríguez-Calvo R, Barroso E, Serrano L, Coll T, Sánchez RM, Merlos M, Palomer FX, Laguna JC and Vazquez M.

    Atorvastatin prevents carbohydrate response element binding protein activation in the fructose-fed rat by activating protein kinase A.

    HEPATOLOGY . 49(1): 106-115. Number of citations: 57

    [doi:10.1002/hep.22570]

  • Coll T, Rodrïguez-Calvo R, Barroso E, Serrano L, Eyre E, Palomer FX and Vazquez M.

    Peroxisome proliferator-activated receptor (PPAR) beta/delta: a new potential therapeutic target for the treatment of metabolic syndrome.

    Current Molecular Pharmacology . 2(1): 46-55.

  • Rodríguez-Calvo R, Serrano L, Coll T, Moullan N, Sánchez RM, Merlos M, Palomer FX, Laguna JC, Michalik L, Wahli W and Vazquez M.

    Activation of peroxisome proliferator-activated receptor beta/delta inhibits lipopolysaccharide-induced cytokine production in adipocytes by lowering nuclear factor-kappaB activity via extracellular signal-related kinase 1/2.

    Diabetes . 57(8): 2149-2157. Number of citations: 101

    [doi:10.2337/db08-0176]